Replies to post #22864 on RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Pfizer tends to want things done 'the Pfizer way', but also tends to lose focus after an initial burst of enthusiasm, leaving projects to founder on their own without a lot of structural support. Wyeth has become more entrepeneurial, but can be a bit sloppy/careless in terms of thoroughly assessing a target and candidates. This could create a conflict--though now that I think of it, Pfizer could resolve that by amputating a lot of the Wyeth R&D operation.

I realize the deal makes sense from an accretion to EPS perspective. I have a problem with corporations whose strategy is based on hitting the cents per share target each quarter, when they could take a nearterm hit and have bigger rewards two years from now. It's that short timeframe perspective that pushes these companies towards incremental changes and me-too drugs.

NeuroInvestment

[haysaw]

Who gives a shit about PFE and WYE coming together in holy matrimony? Really. It is just about a big company buying out another big company to stifle competition. It is ego, and power, and mania. It is bad for America, bad for innovation, and bad for people. The bigger they get, the more corrupt they become. Have we not learned anything from the banks/insurance/brokers and oil/energy? The bigger they are, the more corrupt they become. It is only natural.